Loading…
Lobbying Spend
—
Filings
39
Firms Hired
2
Active Period
2017–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423 / S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401); Increase participation in clinical trials; Clinical Trials Modernization Act (H.R. 3521 / S. 4440).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 3521
Increasing Medication Access for Seniors Act of 2025
2026 · second_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423 / S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401); Increase participation in clinical trials; Clinical Trials Modernization Act (H.R. 3521 / S. 4440).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6401
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423 / S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401); Increase participation in clinical trials; Clinical Trials Modernization Act (H.R. 3521 / S. 4440).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6423
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423 / S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401); Increase participation in clinical trials; Clinical Trials Modernization Act (H.R. 3521 / S. 4440).
Client expense: — · Firm income: $40,000
Matched citations: S. 4440
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423 / S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401); Increase participation in clinical trials; Clinical Trials Modernization Act (H.R. 3521 / S. 4440).
Client expense: — · Firm income: $40,000
Matched citations: S. 864
Increasing Medication Access for Seniors Act of 2025
2026 · first_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6401
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6423
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: S. 864
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 3521
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.
2025 · fourth_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 4184
Increasing Medication Access for Seniors Act of 2025
2025 · fourth_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6401
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6423
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6867
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: S.3564
Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423/S. 864); Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184) and increase participation of underrepresented groups (H.R. 6867/S.3564); Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401).
Client expense: — · Firm income: $40,000
Matched citations: S. 864
Increasing Access to Dental Insurance Act
2025 · third_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1397
Medicare Dental, Vision, and Hearing Benefit Act of 2025
2025 · third_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2045
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 3521
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 4101
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.
2025 · third_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 4184
Gas Pipeline Leak Detection and Repair Act of 2025
2025 · third_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 4818
Increasing Access to Dental Insurance Act
2025 · third_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: S. 1164
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: S. 1973
Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2025
2025 · third_quarter · Firm: VENABLE LLP
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: S. 2084
Prohibiting copay accumulators in ACA Exchange plans: S. 864 - Help Ensure Lower Patient (HELP) Copays Act; Prohibit use of Alternative Funding Programs in private insurance; Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Extend or make permanent Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; Establish Medicare Dental, Vision, and Hearing benefits (H.R. 2045, S. 939, S. 2084, H.R. 1397, S. 1164); Preserve the six protected classes in Medicare Part D; Medicare coverage of anti-obesity medications (S. 1973, H.R. 4818); Maintain Medicaid and Marketplace insurance coverage; Extend Affordable Care Act (ACA) Enhance Premium Tax Credits; Reduce barriers to participation in clinical trials (H.R. 3521, H.R. 4184); Cancer Parity Drug Act (H.R. 4101).
Client expense: — · Firm income: $40,000
Matched citations: S. 864
Source: Senate LDA